ARTICLE | Distillery Therapeutics
Engineered extracellular vesicle nanoplatform for multiplexed lysosomal protein degradation
June 2, 2026 9:06 PM UTC
BCIQ Target Profiles
Microtubule-associated protein 1 light chain 3 beta (MAP1LC3B) (LC3B)
BCIQ Target Profiles
Microtubule-associated protein 1 light chain 3 beta (MAP1LC3B) (LC3B)